Polar Asset Management Partners Inc. lifted its holdings in Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 381.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 621,224 shares of the medical technology company’s stock after purchasing an additional 492,324 shares during the quarter. Polar Asset Management Partners Inc.’s holdings in Alphatec were worth $3,454,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in the business. Van ECK Associates Corp boosted its position in shares of Alphatec by 11.8% in the 2nd quarter. Van ECK Associates Corp now owns 12,275 shares of the medical technology company’s stock worth $128,000 after purchasing an additional 1,300 shares in the last quarter. Atria Investments Inc lifted its position in Alphatec by 8.0% during the 3rd quarter. Atria Investments Inc now owns 19,609 shares of the medical technology company’s stock worth $109,000 after acquiring an additional 1,460 shares during the period. Cetera Advisors LLC lifted its position in Alphatec by 15.6% during the 1st quarter. Cetera Advisors LLC now owns 12,720 shares of the medical technology company’s stock worth $175,000 after acquiring an additional 1,720 shares during the period. Comerica Bank lifted its position in Alphatec by 64.8% during the 1st quarter. Comerica Bank now owns 6,443 shares of the medical technology company’s stock worth $89,000 after acquiring an additional 2,534 shares during the period. Finally, Entropy Technologies LP lifted its holdings in shares of Alphatec by 14.9% in the 3rd quarter. Entropy Technologies LP now owns 21,623 shares of the medical technology company’s stock valued at $120,000 after buying an additional 2,800 shares during the period. Institutional investors and hedge funds own 66.35% of the company’s stock.
Alphatec Trading Up 0.5 %
ATEC opened at $10.05 on Thursday. Alphatec Holdings, Inc. has a one year low of $4.88 and a one year high of $17.34. The stock has a market capitalization of $1.43 billion, a PE ratio of -7.85 and a beta of 1.38. The business’s 50 day moving average price is $7.38 and its 200 day moving average price is $8.18. The company has a debt-to-equity ratio of 30.21, a quick ratio of 1.15 and a current ratio of 2.32.
Wall Street Analysts Forecast Growth
Get Our Latest Analysis on Alphatec
Alphatec Profile
Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.
Read More
- Five stocks we like better than Alphatec
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Tesla Poised to Hit Record Highs This Holiday Season
- What to Know About Investing in Penny Stocks
- The Salesforce Rally is Just Getting Started: Here’s Why
- Investing in Construction Stocks
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Want to see what other hedge funds are holding ATEC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report).
Receive News & Ratings for Alphatec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec and related companies with MarketBeat.com's FREE daily email newsletter.